Cargando…
Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?
While significant advances have been made in the treatment of many different solid tumors, pancreatic cancer remains a glaring exception. Overall 5-year survival rates for pancreatic cancer remain in the single digits. While newer chemotherapy regimens such as FOLFIRINOX and nab-paclitaxel/gemcitabi...
Autores principales: | Satyananda, Vikas, Gupta, Rohan, Hari, Danielle M., Yeh, James, Chen, Kathryn T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378762/ https://www.ncbi.nlm.nih.gov/pubmed/30863442 http://dx.doi.org/10.1155/2019/7690528 |
Ejemplares similares
-
Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023) -
Headache research - where are we heading?
por: Jensen, Rigmor
Publicado: (2013) -
Translational Research in the Era of Precision Medicine: Where We Are and Where We Will Go
por: De Maria Marchiano, Ruggero, et al.
Publicado: (2021) -
Translational Research: Where Do We Go?
por: Kim, Nam Kug, et al.
Publicado: (2012) -
Translational Health Research: where are we going?
por: da Silva, Gilberto Tadeu Reis, et al.
Publicado: (2023)